β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension-Reference-Cited by-同舟云学术

β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension

Published:2009-02 Issue:2 Volume:30 Page:222-228
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Gentile Maria Teresa,Poulet Roberta,Pardo Alba Di,Cifelli Giuseppe,Maffei Angelo,Vecchione Carmine,Passarelli Francesca,Landolfi Alessandro,Carullo Pierluigi,Lembo Giuseppe

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference36 articles.

1. Fresh and globular amyloid beta protein (1–42) induces rapid cellular degeneration: evidence for Abeta P channel mediated cellular toxicity;Batia;FASEB J.,2000

2. Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion;Bennett;Neurobiol. Aging,2000

3. Brain microvascular changes in Alzheimer's disease and other dementias;Buèe;Ann. N.Y. Acad. Sci.,1997

4. Ultrastructural features of the blood brain barrier in biopsy tissue from Alzheimer disease patients;Claudio;Acta Neuropathol.,1996

5. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment;Craft;Curr. Alzheimer Res.,2007

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct effects of blood pressure parameters on Alzheimer’s and vascular markers in 1,952 Asian individuals without dementia;Alzheimer's Research & Therapy;2024-06-11

2. Advanced Magnetic Resonance Imaging to Define the Microvascular Injury Driven by Neuroinflammation in the Brain of a Mouse Model of Hypertension;Hypertension;2024-03

3. Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease;Alzheimer's Research & Therapy;2023-07-14

4. The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease;Current Neuropharmacology;2023-02

5. Hypertension, Neurovascular Dysfunction, and Cognitive Impairment;Hypertension;2023-01